Physician profile
Mervin Low
NPI 1982884219
$13,296.83
in general payments reported to CMS, 2019-2025
13 companies · $8,035 in 2025
The $8,035 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.81 · 2020: $44.95 · 2022: $12.55 · 2023: $1,041 · 2024: $4,150 · 2025: $8,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,109 · Food and Beverage: $5,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,109.25 |
| Food and Beverage | $5,116.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,153.11 | 2020-2025 | Pico, Collagenase Santyl, Versajet |
| Kerecis Limited | $2,869.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $2,524.72 | 2025 | |
| Convatec INC. | $2,481.74 | 2023-2025 | |
| Mimedx Group, INC. | $829.90 | 2024-2025 | |
| Organogenesis INC. | $586.80 | 2023-2025 | Cygnus Dual, Via Matrix, Puraply Am |
| Urgo Medical North America, LLC | $240.33 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Reprise Biomedical, INC. | $160.99 | 2025 | Miro3d |
| Innovation Technologies INC | $124.87 | 2023 | Irrisept |
| Biowound Solutions, INC. | $105.09 | 2024 | Bio-Connekt |
| Bone Support INC. | $101.49 | 2025 | Ceramentbone Void Filler, Cerament G |
| Abbott Laboratories | $91.93 | 2024 | Diamondback Peripheral |
| Tactile Systems Technology INC | $26.64 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mervin Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.